{"database": "openregs", "table": "documents", "rows": [["FDA-2015-E-4020-0008", "FDA", "FDA-2015-E-4020", "Letter from U.S. Patent and Trademark Office to Boehringer Ingelheim Corporation", "Other", "Letter(s)", "2020-09-08T04:00:00Z", 2020, 9, "2020-09-08T04:00:00Z", null, "2020-09-08T19:48:27Z", null, 0, 0, "090000648484b351"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2015-E-4020-0008"], "units": {}, "query_ms": 118.7502850079909, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}